e-Therapeutics plc’ Full Year Results For The 12 Months Ended 31 January 2014
5/12/2014 7:00:26 AM
e-Therapeutics plc (AIM:ETX), the drug discovery and development company, today announces its full year results for the 12 months ended 31 January 2014.
Positive interim results from lead cancer drug ETS2101
•Phase I trial in brain cancer, five dose escalation steps completed, no serious drug-related adverse events
Help employers find you! Check out all the jobs and post your resume.
comments powered by